GI Windows Medical, a West Bridgewater, Mass.-based clinical-stage, medical device company, raised $16.4m in Series A-1 financing.
Backers included Johnson & Johnson Innovation – JJDC, Inc., along with Sonder Capital, GT Healthcare, JC Investco and one additional strategic investor. In addition to the institutional financing, GI Windows also received investments from existing shareholders as well as new investors, the Kennedy Trust and Coleman Trust.
The proceeds will be used to support further product development and clinical studies for the company’s patented technology.
Led by Brian Tinkham, President and Chief Executive Officer, GI Windows Medical is a clinical-stage, medical device company dedicated to developing the first fundamental breakthrough in anastomoses technology in both delivery and tissue fusion. The company was spun out of Beacon Endoscopic (acquired by Covidien in 2014).